Drug intelligence / Profile preview

LY-M003

Development stage
Unknown
Lead developer
Lingyi Biotech
Modality
AAV Vectors → Viral Vectors → Gene Addition/Replacement → Gene Therapies
Administration
Intravenous
01

Overview

LY-M003 is an investigational adeno-associated virus (AAV)-based gene therapy developed by Lingyi Biotech for the treatment of Wilson's disease (hepatolenticular degeneration). The therapy uses a recombinant AAV vector to deliver a functional copy of the ATP7B gene into liver cells via intravenous infusion. This enables long-term expression of ATP7B protein in hepatocytes, aiming to restore copper metabolism, reduce copper accumulation in organs, and improve systemic symptoms associated with Wilson's disease. The drug has received Orphan Drug Designation and Rare Pediatric Disease Designation from the FDA. Clinical trials are ongoing to evaluate its safety, tolerability, and efficacy[1][2][3][4].

Other names
LY-M003LY-M-003LY-M 003LY M003
02

Targets

ATP7B (Copper ion transporter ATPase 7B)

Beyond the preview

Go deeper on LY-M003.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LY-M003.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call